Loading…
China SXT Pharmaceuticals, Inc. is projected to decline to $1.32 by 2027, a -15% move from its current price of $1.55. SXTC is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $1.48 | $1.55 | $1.62 | -0.05% |
| May 30 | $1.45 | $1.55 | $1.65 | -0.09% |
| May 31 | $1.43 | $1.55 | $1.67 | -0.14% |
| Jun 1 | $1.41 | $1.54 | $1.69 | -0.19% |
| Jun 2 | $1.39 | $1.54 | $1.71 | -0.24% |
| Jun 3 | $1.38 | $1.54 | $1.73 | -0.28% |
| Jun 4 | $1.37 | $1.54 | $1.74 | -0.33% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $1.37 | $1.54 | $1.74 | -0.33% |
| Week 2 | $1.30 | $1.54 | $1.82 | -0.66% |
| Week 3 | $1.24 | $1.53 | $1.89 | -0.99% |
| Week 4 | $1.20 | $1.53 | $1.94 | -1.32% |
| Week 5 | $1.16 | $1.52 | $1.99 | -1.64% |
| Week 6 | $1.13 | $1.52 | $2.04 | -1.97% |
| Week 7 | $1.10 | $1.51 | $2.08 | -2.29% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
China SXT Pharmaceuticals, Inc. (SXTC) is a healthcare company focused on traditional Chinese medicine pieces (TCMP) in China.
The company engages in the research, development, manufacture, marketing, and sale of TCMP products and raw medicinal materials, including SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, ShaRen, and ChenXiang.
Products are marketed under the Suxuantang, Hui Chun Tang, and Tong Ren Tang brands, serving pharmaceutical companies, chain pharmacies, hospitals, and distributors. The company was incorporated in 2005 and is headquartered in Taizhou, China.
SXTC is a healthcare stock trading in the small-cap space. It is currently priced at $1.66 per share with a market capitalization of $7.4M and a rank of 5242.
The 30-day technical picture shows neutral sentiment, with RSI14 at 30, a 50-day simple moving average of $1.81, and a 200-day SMA of $123.96. The price sits between support at $1.55 and resistance at $2.32, and the 30-day price range runs from $1.23 to $2.24.
Forecasts for 2026 place the average at $1.66 (min $1.30, max $2.14) with 0% ROI and a Neutral stance. Looking further out, the sequence shows a path from modest growth to stronger gains, with 2031 at an avg of $1.97, 2032 at $2.00, 2040 at $2.44, and 2050 at $4.72, accompanied by ROIs of 18.6%, 20.5%, 46.9%, and 184.4% respectively and a generally bullish tone in the later years.
A major floor 24.7% below — a decisive break under it would weaken the trend.
Price is testing support right now (0.0% away) — a key level to hold.
The nearest ceiling, 37.0% above — a clean break opens room to run.
A major ceiling 888.6% above — clearing it would confirm fresh momentum.
Key SXTC support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of SXTC market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $1.62 | Sell | $1.61 | Sell |
| MA 10 | $1.60 | Sell | $1.63 | Sell |
| MA 20 | $1.72 | Sell | $1.72 | Sell |
| MA 50 | $1.80 | Sell | $7.07 | Sell |
| MA 100 | $16.40 | Sell | $36.57 | Sell |
| MA 200 | $121.60 | Sell | $92.57 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 31.63 | Neutral |
| Stoch RSI (14) | 43.27 | Neutral |
| CCI (20) | -78.92 | Neutral |
| Williams %R (14) | -100.00 | Info |
| MACD (12,26,9) | 0.08 | Buy |
| ROC (12) | -10.52 | Sell |
| Bollinger %B (20,2) | 0.26 | Neutral |
| Stochastic %K (14) | 0.00 | Buy |
| TRIX (15) | -1.12 | Sell |
| Awesome (5,34) | -0.25 | Sell |
| Ultimate (7,14,28) | 39.55 | Neutral |
| Momentum (10) | -0.05 | Sell |
| Aroon Osc (25) | -92.00 | Sell |
| Hull MA (9) | 1.65 | Sell |
| ADX (14) | 36.75 | Sell |
| ATR (14) | 0.09 | Info |
The 30-day picture is neutral, with RSI14 at 30. The stock trades with the 50-day SMA at $1.81 and the 200-day SMA at $123.96. Immediate price action faces support near $1.55 and a barrier at $2.32.
Over the last 30 days the price has oscillated within a $1.23 to $2.24 range, highlighting modest volatility around the current level of $1.66.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $1.30 | $1.55 | $1.99 | 0% | Neutral | |
| $0.9811 | $1.32 | $1.92 | -15% | Neutral | |
| $0.9754 | $1.38 | $2.12 | -11% | Neutral | |
| $0.8543 | $1.26 | $2.02 | -18% | Bearish | |
| $0.9291 | $1.42 | $2.36 | -8% | Neutral | |
| $1.14 | $1.81 | $3.10 | +17% | Neutral | |
| $1.14 | $1.87 | $3.29 | +21% | Bullish | |
| $1.06 | $1.80 | $3.23 | +16% | Neutral | |
| $0.9035 | $1.58 | $2.91 | +2% | Neutral | |
| $0.8886 | $1.60 | $3.01 | +3% | Neutral | |
| $1.08 | $2.25 | $4.61 | +46% | Bullish | |
| $1.98 | $4.40 | $10.13 | +185% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $1.30 | $1.55 | $1.83 | +0.00% |
| June 2026 | $1.25 | $1.49 | $1.83 | -4.00% |
| July 2026 | $1.23 | $1.48 | $1.86 | -0.23% |
| August 2026 | $1.26 | $1.54 | $1.97 | +4.01% |
| September 2026 | $1.22 | $1.50 | $1.95 | -2.57% |
| October 2026 | $1.14 | $1.42 | $1.86 | -5.60% |
| November 2026 | $1.15 | $1.44 | $1.91 | +1.80% |
| December 2026 | $1.18 | $1.49 | $1.99 | +2.99% |
Click any year to see its month-by-month SXTC forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
China SXT Pharmaceuticals, Inc.'s 2026 outlook centres on $1.55, within a $1.30 to $1.99 range. That marks a 0% change versus current levels. A consolidation phase looks the most probable path here.
By 2027, SXTC could reach as high as $1.92, with a base case around $1.32 and support toward $0.9811 — roughly -15% from $1.55. Price action looks broadly range-bound.
Expect SXTC to range from $0.9754 to $2.12 through 2028. The $1.38 average target implies a -11% move from current prices. That is up +4% on the projected 2027 average. A consolidation phase looks the most probable path here.
The SXTC price prediction for 2029 points to an average of $1.26 (low $0.8543, high $2.02) — a potential decline of -18% on today's $1.55. A cyclical pullback looks likely — prices rarely move in a straight line.
In 2030, SXTC is projected to trade between $0.9291 and $2.36, averaging $1.42 — a potential decline of -8% from today's $1.55. That is up +13% on the projected 2029 average. A consolidation phase looks the most probable path here.
China SXT Pharmaceuticals, Inc.'s 2031 outlook centres on $1.81, within a $1.14 to $3.10 range. That is up +27% on the projected 2030 average. That marks a +17% change versus current levels. Price action looks broadly range-bound.
By 2032, SXTC could reach as high as $3.29, with a base case around $1.87 and support toward $1.14 — roughly +21% from $1.55. Buyers look set to stay in control over this stretch.
Expect SXTC to range from $1.06 to $3.23 through 2033. The $1.80 average target implies a +16% move from current prices. That is -4% versus the projected 2032 average. Price action looks broadly range-bound.
The SXTC price prediction for 2034 points to an average of $1.58 (low $0.9035, high $2.91) — a potential gain of +2% on today's $1.55. A consolidation phase looks the most probable path here.
In 2035, SXTC is projected to trade between $0.8886 and $3.01, averaging $1.60 — a potential gain of +3% from today's $1.55. That is up +1% on the projected 2034 average. Price action looks broadly range-bound.
China SXT Pharmaceuticals, Inc.'s 2040 outlook centres on $2.25, within a $1.08 to $4.61 range. That is up +41% on the projected 2035 average. That marks a +46% change versus current levels. Buyers look set to stay in control over this stretch.
By 2050, SXTC could reach as high as $10.13, with a base case around $4.40 and support toward $1.98 — roughly +185% from $1.55. Momentum favours further upside here.
Investing $1,000 in SXTC today (≈ 646.120049 SXTC) could be worth
$2,845.98
+$1,845.98 (+185%) by 2050 · US Dollar
Based on the average projected SXTC price of $4.4 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in SXTCwould be worth at today's price.
$1,000 invested in SXTC on May 27, 2025 (≈ 4.415011 SXTC) would be worth
$6.83
-$993.17 (-99.3%) today · 0.01× · US Dollar
Based on a SXTC entry price of $226.5 vs. today's $1.55.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $1.6 | $967.31 | -3.3% |
| 1 month ago | $2.08 | $744.09 | -25.6% |
| 3 months ago | $2.42 | $639.55 | -36.0% |
| 6 months ago | $216 | $7.17 | -99.3% |
| 1 year ago | $226.5 | $6.83 | -99.3% |
| All time (5.0y) ago | $5,175 | $0.3 | -100.0% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our SXTC forecast.
Our base-case forecast reaches $3.10 around 2050.
Implied market cap at $3.10: $13.82M
2030: The average forecast for 2030 is $1.52 with a min of $0.9904 and a max of $2.52, representing a -8.4% ROI and a Neutral sentiment.
2031: The average forecast rises to $1.97 with a min of $1.24 and a max of $3.37, delivering an 18.6% ROI and a Neutral stance.
2032: The average forecast is $2.00, with a min of $1.22 and a max of $3.52, and a 20.5% ROI with a Bullish tilt.
2040: The average forecast increases to $2.44, with a min of $1.17 and a max of $4.99, a 46.9% ROI and a Bullish stance.
2050: The long-range view shows an average of $4.72, a min of $2.12 and a max of $10.86, a 184.4% ROI and a Bullish stance.
Taken together, the multi-year view points to a shift from near-term stabilization to meaningful upside by the late 2020s and into the 2040s and 2050s, though early years include modest to negative returns. These figures are estimates and carry inherent uncertainty.
Tap a question to reveal the answer.
The 2030 forecast shows an average price of $1.52, with a minimum of $0.9904 and a maximum of $2.52. That case implies a -8.4% ROI and a Neutral sentiment.
Near term, the forecast includes years like 2027 with a -15.1% ROI and 2029 with -18.9% ROI, indicating bearish periods. Longer term, years such as 2031 (18.6% ROI), 2032 (20.5%), 2040 (46.9%), and 2050 (184.4%) show positive potential, with sentiment turning bullish in later years.
Yes, the long-range forecast for 2050 shows an average of $4.72 and a high of $10.86, indicating a path that could exceed $4 within the forecast horizon.
Current price is $1.66 and market cap is $7.4M. It is ranked 5242.
The 30-day range is $1.23 to $2.24. Nearby support is at $1.55 and resistance at $2.32.
China SXT Pharmaceuticals, Inc. Community Discussion
0Share your China SXT Pharmaceuticals, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.